APUS
AMEX · Biotechnology
Apimeds Pharmaceuticals Us I
$1.91
+0.28 (+17.18%)
Open$1.64
Previous Close$1.63
Day High$1.91
Day Low$1.62
52W High$206.00
52W Low—
Volume—
Avg Volume29.0K
Market Cap20.50M
P/E Ratio—
EPS$-0.12
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 11.55M | 12.01M | 11.14M |
| Net Income | 858.8K | 710.2K | 724.1K |
| Profit Margin | 7.4% | 5.9% | 6.5% |
| EBITDA | 1.04M | 1.13M | 1.04M |
| Free Cash Flow | 935.0K | 714.0K | 1.10M |
| Rev Growth | -8.4% | +17.9% | -7.5% |
| Debt/Equity | 0.40 | 0.38 | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.87 | -1.20% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $354.05 | +0.63% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.73 | +0.98% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $449.71 | +0.71% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $776.21 | +0.46% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |